Abstract
Conventional cancer treatment methods suffer from many limitations such as non-specificity and low efficacy in discrimination between healthy and cancer cells. Recent developments in nanotechnology have introduced novel and smart therapeutic nanomaterials that basically take advantage of various targeting approaches. Targeted nanomaterials selectively bind to the cancer cells and affect them with minor effects on healthy cells. Folic acid (folate) is an essential molecule in DNA synthesis pathway which is highly needed for cancer cell duplication. Some certain cancer cells overexpress folate receptors higher than normal cells, and this fact is the basis of folate targeting strategy. There are many publications reporting various folate conjugated nanomaterials among which folate-conjugated gold nanoparticles hold great promises in targeted cancer therapy. Gold nanoparticles have been identified as promising candidates for new cancer therapy modalities because of biocompatibility, easy synthesis and functionalization, chemo-physical stability, and optical tunable characteristics. In the last decade, there has been a significant explosion in gold nanoparticles research, with a rapid increase in publications related to the area of biomedicine. Although there are many reports published on “gold nanoparticles” and “folate targeting,” there are a few reports on “folate-conjugated gold nanoparticles” in biomedical literature. This paper intends to review and illustrate the recent advances in biomedicine which have been designed on the basis of folate-conjugated gold nanoparticles.
Similar content being viewed by others
References
Asadishad B, Vossoughi M, Alemzadeh I (2010) Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles. Ind Eng Chem Res 49(4):1958–1963
Bazak R et al (2014) Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 141(5):769–784
Bazak R et al (2014) Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 141(5):769–784
Begg A et al (1987) Radiosensitization in vitro by cis-diammine (1, 1-cyclobutanedicarboxylato) platinum (II)(carboplatin, JM8) and ethylenediammine-malonatoplatinum (II)(JM40). Radiother Oncol 9(2):157–165
Beik J et al (2016) Evaluation of the sonosensitizing properties of nano-graphene oxide in comparison with iron oxide and gold nanoparticles. Phys E 81:308–314
Bertrand N et al (2014) Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25
Bharali DJ, Mousa SA (2010) Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther 128(2):324–335
Biselli-Chicote P et al (2012) VEGF gene alternative splicing: pro-and anti-angiogenic isoforms in cancer. J Cancer Res Clin Oncol 138(3):363–370
Bohren CF, Huffman DR (2008) Absorption and scattering of light by small particles. Wiley, London
Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54(5):631–651
Brun E, Sanche L, Sicard-Roselli C (2009) Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution. Colloids Surf B 72(1):128–134
Byrne JD, Betancourt T, Brannon-Peppas L (2008) Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60(15):1615–1626
Cai W et al (2008) Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 1:17
Cai H-H et al (2015) Gold nanoprobes-based resonance rayleigh scattering assay platform: Sensitive cytosensing of breast cancer cells and facile monitoring of folate receptor expression. Biosens Bioelectron 74:165–169
Chen J et al (2005) Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett 5(3):473–477
Chen J et al (2007) Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 7(5):1318–1322
Cheng H et al (2015) Gold nanoparticle-enhanced near infrared fluorescent nanocomposites for targeted bio-imaging. RSC Adv 5(1):20–26
Chithrani DB et al (2010) Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 173(6):719–728
Das M, Mohanty C, Sahoo SK (2009) Ligand-based targeted therapy for cancer tissue. Expert Opin Drug Deliv 6(3):285–304
del Burgo LS, Pedraz J, Orive G (2014) Advanced nanovehicles for cancer management. Drug Discov Today 19(10):1659–1670
Dharmatti R et al (2014) Surface orchestration of gold nanoparticles using cysteamine as linke r and folate as navigating molecule for synaphic delivery of doxorubicin. J Nanomed Res 1(1):00002
Drouet F, Lagrange J-L (2010) Dose de tolérance à l’irradiation des tissus sains: la moelle osseuse. Cancer/Radiothérapie 14(4):392–404
Fazilati M (2014) Folate decorated magnetite nanoparticles: synthesis and targeted therapy against ovarian cancer. Cell Biol Int 38(2):154–163
Garin-Chesa P et al (1993) Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol 142(2):557
Geng J et al (2012) Conjugated polymer and gold nanoparticle co-loaded PLGA nanocomposites with eccentric internal nanostructure for dual-modal targeted cellular imaging. Small 8(15):2421–2429
Ghaznavi H et al (2015) Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population. Blood Coagul Fibrinolysis 26(8):869–873. doi:10.1097/MBC.0000000000000292
Ghaznavi H et al (2015) The neuro-protective effects of cerium and yttrium oxide nanoparticles on high glucose-induced oxidative stress and apoptosis in undifferentiated PC12 cells. Neurol Res 37(7):624–632. doi:10.1179/1743132815Y.0000000037
Hainfeld JF, Slatkin DN, Smilowitz HM (2005) The use of gold nanoparticles to enhance radiotherapy in mice. Cancer Res 65(9 Supplement):287
Hainfeld JF et al (2008) Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 60(8):977–986
Hering K et al (2008) SERS: a versatile tool in chemical and biochemical diagnostics. Anal Bioanal Chem 390(1):113–124
Huang P et al (2011) Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 32(36):9796–9809
Huff TB et al (2007) Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2(1):125–132. doi:10.2217/17435889.2.1.125
Jain S, Hirst D, O’sullivan J (2012) Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 85(1010):101–113. doi:10.1259/bjr/59448833
Jin H et al (2012) Photothermal effects of folate-conjugated Au nanorods on HepG2 cells. Appl Microbiol Biotechnol 94(5):1199–1208
Kennedy LC et al (2011) A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 7(2):169–183
Kerker M (2013) The scattering of light and other electromagnetic radiation: physical chemistry—a series of monographs, vol 16. Academic press, Cambridge
Khoei S et al (2014) The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies. Int J Radiat Biol 90(5):351–356
Khoshgard K et al (2014) Radiosensitization effect of folate-conjugated gold nanoparticles on HeLa cancer cells under orthovoltage superficial radiotherapy techniques. Phys Med Biol 59(9):2249
Kirpotin DB et al (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 66(13):6732–6740
Kong T et al (2008) Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 4(9):1537–1543
Kreuter J (2007) Nanoparticles—a historical perspective. Int J Pharm 331(1):1–10
Kukowska-Latallo JF et al (2005) Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65(12):5317–5324
Li J-L et al (2009) In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett 274(2):319–326
Li R et al (2011) Folate and iron difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cells. Carbon 49(5):1797–1805
Li W et al (2015) Radionuclide therapy using 131I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression. J Cancer Res Clin Oncol 142(3):619–632
Link S, El-Sayed MA (2000) Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem 19(3):409–453
Liu C-J et al (2010) Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 55(4):931
Maeda H et al (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controll Release 65(1):271–284
Mansoori GA, Brandenburg KS, Shakeri-Zadeh A (2010) A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications. Cancers 2(4):1911–1928
Mehdizadeh A et al (2014) The effects of folate-conjugated gold nanorods in combination with plasmonic photothermal therapy on mouth epidermal carcinoma cells. Lasers Med Sci 29(3):939–948
Misra R, Acharya S, Sahoo SK (2010) Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today 15(19):842–850
Mitra RN et al (2012) An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials 33(5):1500–1508
Pandey S et al (2013) Biogenic gold nanoparticles as fotillas to fire berberine hydrochloride using folic acid as molecular road map. Mater Sci Eng C 33(7):3716–3722
Papavassiliou GC (1979) Optical properties of small inorganic and organic metal particles. Prog Solid State Chem 12(3):185–271
Parker N et al (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338(2):284–293
Parveen S, Sahoo SK (2008) Polymeric nanoparticles for cancer therapy. J Drug Target 16(2):108–123
Patra CR et al (2008) Application of gold nanoparticles for targeted therapy in cancer. J Biomed Nanotechnol 4(2):99–132
Prabaharan M et al (2009) Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 30(30):6065–6075
Rahman WN et al (2009) Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomed Nanotechnol Biol Med 5(2):136–142
Rathinaraj P et al (2015) Targeted images of KB cells using folate-conjugated gold nanoparticles. Nanoscale Res Lett 10(1):1–10
Rozenberg M, Shoham G (2007) FTIR spectra of solid poly-l-lysine in the stretching NH mode range. Biophys Chem 125(1):166–171
Saw PE et al (2013) Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy. J Mater Chem B 1(37):4723–4726
Sha MY et al (2007) SERS nanoparticles: a new optical detection modality for cancer diagnosis. Nanomedicine 2(5):725–734. doi:10.2217/17435889.2.5.725
Shakeri-Zadeh A et al (2013) Targeted, monitored, and controlled chemotherapy: a multimodal nanotechnology-based approach against cancer. ISRN Nanotechnol 2013:5. doi:10.1155/2013/629510
Shakeri-Zadeh A et al (2009) Gold nanoparticles conjugated with folic acid using mercaptohexanol as the linker. JONPI 1:13–23
Shakeri-Zadeh A, Ghasemifard M, Mansoori GA (2010a) Structural and optical characterization of folate-conjugated gold-nanoparticles. Phys E 42(5):1272–1280
Shakeri-Zadeh A et al (2010b) Cancerous cells targeting and destruction using folate-conjugated gold nanoparticles. Dyn Biochem Process Biotechnol Mol Biol 4(1):06–12
Shakeri-Zadeh A et al (2014a) A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model. J Biomater Appl 29(4):548–556
Shakeri-Zadeh A et al (2014b) A scientific paradigm for targeted nanophotothermolysis; the potential for nanosurgery of cancer. Lasers Med Sci 29(2):847–853
Shakeri-Zadeh A et al (2015a) Synergistic effects of magnetic drug targeting using a newly developed nanocapsule and tumor irradiation by ultrasound on CT26 tumors in BALB/c mice. J Mater Chem B 3(9):1879–1887
Shakeri-Zadeh A et al (2015b) Combination of ultrasound and newly synthesized magnetic nanocapsules affects the temperature profile of CT26 tumors in BALB/c mice. J Med Ultrason 42(1):9–16
Singhal S, Nie S, Wang MD (2010) Nanotechnology applications in surgical oncology. Annu Rev Med 61:359
Sinha R et al (2006) Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 5(8):1909–1917
Sivakumar B et al (2014) Bacterial exopolysaccharide based magnetic nanoparticles: a versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy. J Biomed Nanotechnol 10(6):885–899
Soltanpour MS et al (2013) Methylenetetrahydrofolate reductase C677T mutation and risk of retinal vein thrombosis. J Res Med Sci 18(6):487
Svaasand LO, Gomer CJ, Morinelli E (1990) On the physical rationale of laser induced hyperthermia. Lasers Med Sci 5(2):121–128
Syu WJ et al (2012) Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model. Small 8(13):2060–2069
Talekar M et al (2011) Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anticancer Drugs 22(10):949–962
Tiwari PM et al (2011) Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1(1):31–63
Tong L et al (2007) Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv Mater 19(20):3136–3141
Tork MB et al (2014) In situ green synthesis of silver nanoparticles/chitosan/poly vinyl alcohol/poly ethylene glycol hydrogel nanocomposite for novel finishing of nasal tampons. J Ind Text 45(6):1399–1416. doi:10.1177/1528083714560255
Veigele WJ (1973) Photon cross sections from 0.1 keV to 1 MeV for elements Z = 1 to Z = 94. Atomic Data Nucl Data Tables 5(1):51–111
Wang Y et al (2015) A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer. J Cancer Res Clin Oncol 142(4):813–821
Yin M et al (2012) Water-dispersible multiwalled carbon nanotube/iron oxide hybrids as contrast agents for cellular magnetic resonance imaging. Carbon 50(6):2162–2170
Yoo HS, Park TG (2004) Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugate. J Control Release 100(2):247–256
Yu B et al (2010) Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol 27(7):286–298
Zhang Z et al (2010) Conjugating folic acid to gold nanoparticles through glutathione for targeting and detecting cancer cells. Bioorganic Med Chem 18(15):5528–5534
Zhang X-Q et al (2012a) Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv Drug Deliv Rev 64(13):1363–1384
Zhang X-D et al (2012b) Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33(27):6408–6419
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Samadian, H., Hosseini-Nami, S., Kamrava, S.K. et al. Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol 142, 2217–2229 (2016). https://doi.org/10.1007/s00432-016-2179-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2179-3